Arvid Carlsson - Selected references#


  • CARLSSON, A. Pharmacology of selective dopamine receptor agonists. In: Trends in Medicinal Chemistry (eds. E. Mutschler and E. Winterfeldt). Proceedings of the Ninth International Symposium on Medicinal Chemistry, Berlin 1986. VCH Verlagsgesellschaft mbH, D-6940 Weinheim, 1987 pp. 313-321.
  • CARLSSON, A. The dopamine hypothesis of schizophrenia 20 years later. In: Search for the Cause of Schizophrenia (eds. H. Häffler, W.F. Gattaz, and W. Janzarik). Springer-Verlag, Berlin Heidelberg 1987, pp. 223-235.
  • CARLSSON, A. Historical perspective of the chemistry and pharmacological treatment of schizophrenia. In: Handbook of Schizophrenia, Vol. 2: Neurochemistry and Neuropharmacology of Schizophrenia (eds. F.A. Herm and L.E. DeLisi). Elsevier Science Publishers B.V., 1987, pp. 1-15.
  • CARLSSON, A. Perspectives on the discovery of central monoaminergic neurotransmission. Ann. Rev. Neurosci. 1987. 10. 19-40.
  • CARLSSON, A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacol. 1988. 1. 179-186.
  • CARLSSON, M., and A. CARLSSON. The NMDA antagonist MK-801 causes marke locomotor stimulation in monoamine-depleted mice. J. Neural Transm. 1989. 75. 221-226.
  • CARLSSON, M., and A. CARLSSON. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J. Neural Transm. 1989. 77. 65-71.
  • CARLSSON, A. Early psychopharmacology and the rise of modern brain research. J. Psychopharmacol. 1990. 4(3). 120-126.
  • CARLSSON, M., and A. CARLSSON. Interactions between glutamatergic and mono-aminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. TINS. 1990. 13. 272-276.
  • CARLSSON, A., and B. FORNSTEDT. Possible mechanisms underlying the special vulnerability of dopaminergic neurons. Acta Neurol. Scand. 1991. 84. 16-18.
  • HANSSON, L.O., N. WATERS, B. WINBLAD, C.-G. GOTTFRIES, and A. CARLSSON. Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortem brain tissue. J. Neural Transm. 1994. 98. 217-235.
  • SVENSSON, K, A. CARLSSON, and N. WATERS. Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. 1994. 95. 71-74.
  • WATERS, N., L. LÖFBERG, S. HAADSMA-SVENSSON, K. SVENSSON, C. SONESSON, and A. CARLSSON. Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J. Neural Transm. 1994. 98. 39-55.
  • BUNNEY, B.G., W.E. BUNNEY, jr., and A. CARLSSON. Schizophrenia and glutamate. Chapter 101 in: Psychopharmacology. The Fourth Generation of Progress (eds. F.E. Bloom and D.J. Kupfer). Raven Press, Ltd., New York 1995, pp. 1205-1214.
  • CARLSSON, A. Towards a new understanding of dopamine receptors. Clin. Neuropharmacol. 1995.18 (suppl. 1). S6-SI3.
  • CARLSSON, A. The dopamine theory revisited. In: Schizophrenia (eds. S.R. Hirsch and D.R. Weiberger). Blackwell Science, Oxford 1995, pp. 379-400.
  • SVENSSON, A, M.L. CARLSSON, and A. CARLSSON. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice. J. Neural Transm. 1995. 101. 127-148.


Imprint Privacy policy « This page (revision-2) was last updated on Wednesday, 24. October 2012, 11:19 by Nowak Aleksandra
  • operated by